title: Who is going to benefit from nystatin prophylaxis for fungal peritonitis complicating CAPD?
authors.forename: W K
authors.initials: WK
authors.lastname: Lo
authors.forename: I K
authors.initials: IK
authors.lastname: Cheng
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D006801:Humans; D009181:Mycoses / Q000209:etiology / Q000517:prevention & control*; D009761:Nystatin / Q000627:therapeutic use*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*
chemical_list: D000935:Antifungal Agents; D009761:Nystatin